Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects
Thomas J Raife1, Donna J Lager
1Department of Pathology, University of Iowa, Iowa City 52242, USA. thomas-raife@uiowa.edu
Objective:
To describe 6 patients who developed progressive renal failure and renal thrombotic microangiopathy (TM) not accompanied by the characteristic hematologic disturbances of TM syndromes.
Patients And Methods:
Portions of renal biopsy specimens from each patient were examined by light and electron microscopy for histopathologic evidence of TM. Antecedent clinical events, laboratory evidence of hemolysis and thrombocytopenia, and clinical outcome were documented. Medical records were reviewed and clinical data, including laboratory values, treatment, and outcome, were recorded.
Results:
In each case, a slowly progressive uremia evolved after radiation and/or chemotherapy without laboratory evidence of acute hemolysis or thrombocytopenia. Renal biopsy specimens in all cases showed TM and tubulointerstitial scarring, suggesting both acute and chronic renal injury. Two of the 6 patients underwent plasma exchange therapy without improvement of renal function. Three patients treated with angiotensin-converting enzyme inhibitors for coexisting systemic hypertension remained stable or had mild improvement in renal function.
Conclusions:
A small subset of patients treated for malignancy developed slowly evolving uremia associated with renal TM without marked hematologic abnormalities. In the absence of thrombocytopenia and other typical laboratory findings, the diagnosis of renal TM may be overlooked.
Insights
A small group of cancer patients developed kidney failure and thrombotic microangiopathy (TM) without typical blood disorder signs. This renal TM may be missed if not specifically looked for in these patients.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Thrombotic microangiopathy (TM) typically presents with hemolytic anemia and thrombocytopenia.
- Renal involvement in TM can lead to progressive renal failure.
Observation:
- Six patients undergoing cancer treatment developed progressive renal failure.
- These patients exhibited renal thrombotic microangiopathy (TM) on biopsy.
- Characteristic hematologic disturbances of TM were notably absent.
Findings:
- Patients presented with slowly evolving uremia following radiation and/or chemotherapy.
- Renal biopsies revealed TM alongside tubulointerstitial scarring, indicating acute and chronic injury.
- Plasma exchange did not improve renal function in two patients.
- Angiotensin-converting enzyme inhibitors stabilized or mildly improved renal function in three hypertensive patients.
Implications:
- A subset of cancer patients can develop renal TM without overt hematologic abnormalities.
- The diagnosis of renal TM may be overlooked in the absence of typical laboratory findings.
- This highlights the importance of renal biopsy in diagnosing unexplained renal failure in cancer patients.
Related Concept Videos
Drugs that Stabilize Microtubules
Chronic Kidney Disease II: Clinical Manifestations
Venous Thrombosis III: Interprofessional Care
Drugs that Destabilize Microtubules

